Arkolith/Insider Trading/BMRN/Form 4

Hardy Alexander

Chief Executive Officer, DirectorBIOMARIN PHARMACEUTICAL INC (BMRN) · full profile →Form 4 · filed Dec 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 29, 2024Tax withholding(F)14K$66.03$944K134K
Oct 31, 2024Grant(A)300$56.01$17K148K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001048477-24-000156) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML